Poseida Therapeutics, Inc. Share-based Payment Arrangement, Expense
Poseida Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $4.96 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-11-07
- Poseida Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $4.96M, a 3.09% decline year-over-year.
- Poseida Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $7.63M, a 39.37% increase year-over-year.
- Poseida Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-03-31 was $5.38M, a 28.03% decline year-over-year.
- Poseida Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-12-31 was $5.06M, a 11.32% increase year-over-year.
- Poseida Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $23.13M, a 22.23% increase from fiscal 2022.
- Poseida Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $18.93M, a 13.30% increase from fiscal 2021.
- Poseida Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2021 was $16.70M, a 131.36% increase from fiscal 2020.
- Poseida Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2020 was $7.22M, a 136.72% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $4.96M 10-Q · filed 2024-11-07 | $12.59M derived: sum of 2 quarters · filed 2024-11-07 | $17.97M 10-Q · filed 2024-11-07 | $23.03M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $7.63M 10-Q · filed 2024-08-05 | $13.01M 10-Q · filed 2024-08-05 | $18.07M derived: sum of 3 quarters · filed 2024-08-05 | $23.19M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | $5.38M 10-Q · filed 2024-05-14 | $10.45M derived: sum of 2 quarters · filed 2024-05-14 | $15.56M derived: sum of 3 quarters · filed 2024-11-07 | $21.04M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $10.18M derived: sum of 2 quarters · filed 2024-11-07 | $15.65M derived: sum of 3 quarters · filed 2024-11-07 | $23.13M 10-K · filed 2024-03-07 |
| 2023-09-30 | $5.12M 10-Q · filed 2024-11-07 | $10.59M derived: sum of 2 quarters · filed 2024-11-07 | $18.07M 10-Q · filed 2024-11-07 | $22.62M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $5.47M 10-Q · filed 2024-08-05 | $12.95M 10-Q · filed 2024-08-05 | $17.50M derived: sum of 3 quarters · filed 2024-08-05 | $21.78M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $7.48M 10-Q · filed 2024-05-14 | $12.03M derived: sum of 2 quarters · filed 2024-05-14 | $16.30M derived: sum of 3 quarters · filed 2024-05-14 | $21.54M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $8.82M derived: sum of 2 quarters · filed 2024-03-07 | $14.06M derived: sum of 3 quarters · filed 2024-03-07 | $18.93M 10-K · filed 2024-03-07 |
| 2022-09-30 | $4.28M 10-Q · filed 2023-11-09 | $9.51M derived: sum of 2 quarters · filed 2023-11-09 | $14.38M 10-Q · filed 2023-11-09 | $18.73M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $5.23M 10-Q · filed 2023-08-08 | $10.10M 10-Q · filed 2023-08-08 | $14.45M derived: sum of 3 quarters · filed 2023-08-08 | $18.60M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $4.87M 10-Q · filed 2023-05-09 | $9.22M derived: sum of 2 quarters · filed 2023-05-09 | $13.37M derived: sum of 3 quarters · filed 2023-05-09 | $18.11M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $8.50M derived: sum of 2 quarters · filed 2023-03-09 | $13.24M derived: sum of 3 quarters · filed 2023-03-09 | $16.70M 10-K · filed 2023-03-09 |
| 2021-09-30 | $4.15M 10-Q · filed 2022-11-10 | $8.89M derived: sum of 2 quarters · filed 2022-11-10 | $12.36M 10-Q · filed 2022-11-10 | $14.56M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $4.74M 10-Q · filed 2022-08-11 | $8.20M 10-Q · filed 2022-08-11 | $10.40M derived: sum of 3 quarters · filed 2022-08-11 | $12.30M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $3.46M 10-Q · filed 2022-05-12 | $5.66M derived: sum of 2 quarters · filed 2022-05-12 | $7.56M derived: sum of 3 quarters · filed 2022-05-12 | $9.17M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $4.10M derived: sum of 2 quarters · filed 2022-03-10 | $5.71M derived: sum of 3 quarters · filed 2022-03-10 | $7.22M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.90M 10-Q · filed 2021-11-09 | $3.51M derived: sum of 2 quarters · filed 2021-11-09 | $5.02M 10-Q · filed 2021-11-09 | $6.33M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.62M 10-Q · filed 2021-08-12 | $3.13M 10-Q · filed 2021-08-12 | $4.44M derived: sum of 3 quarters · filed 2021-08-12 | $5.11M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.51M 10-Q · filed 2021-05-11 | $2.82M derived: sum of 2 quarters · filed 2021-05-11 | $3.50M derived: sum of 3 quarters · filed 2021-05-11 | $4.11M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.99M derived: sum of 2 quarters · filed 2021-03-11 | $2.60M derived: sum of 3 quarters · filed 2021-03-11 | $3.05M 10-K · filed 2021-03-11 |
| 2019-09-30 | $676.00K 10-Q · filed 2020-11-12 | $1.28M derived: sum of 2 quarters · filed 2020-11-12 | $1.74M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $607.00K 10-Q · filed 2020-08-20 | $1.06M 10-Q · filed 2020-08-20 |